Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 2
2003 1
2004 4
2005 4
2006 4
2007 3
2008 4
2009 5
2010 6
2011 10
2012 3
2013 6
2014 6
2015 5
2016 1
2017 3
2018 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Transglutaminase 2 and neuroinflammation.
Ientile R, Currò M, Caccamo D. Ientile R, et al. Amino Acids. 2015 Jan;47(1):19-26. doi: 10.1007/s00726-014-1864-2. Epub 2014 Nov 15. Amino Acids. 2015. PMID: 25398223 Review.
Several findings emphasize the possible role of the TG2/NF-kappaB activation pathway in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis. ...
Several findings emphasize the possible role of the TG2/NF-kappaB activation pathway in neurodegenerative diseases, including Alzheimer's …
Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.
Lai TS, Lin CJ, Wu YT, Wu CJ. Lai TS, et al. Front Biosci (Landmark Ed). 2017 Mar 1;22(7):1114-1137. doi: 10.2741/4536. Front Biosci (Landmark Ed). 2017. PMID: 28199195 Free article. Review.
One calcium-activated enzyme with demonstrated pathophysiological important in mitochondrial disease is tissue transglutaminase (TG2). TG2 is known as a post-translational modification (PTM) enzyme that is induced by oxidative stress. ...Here, we summarize dysfunctional mi …
One calcium-activated enzyme with demonstrated pathophysiological important in mitochondrial disease is tissue transglutaminase (TG2) …
[Transglutaminase and neurodegenerative diseases].
Liu Z, Zeng J, Zeng S, Tang B, Wang J. Liu Z, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Aug;32(4):562-6. doi: 10.3760/cma.j.issn.1003-9406.2015.04.025. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. PMID: 26252108 Review. Chinese.
TGase has been found to contribute to a variety of important physiological and pathological processes and play a role in the pathogenesis of multiple diseases. Notably, neurodegenerative diseases such as Huntington's disease, spinocerebellar ataxia, Alzheimer's disease
TGase has been found to contribute to a variety of important physiological and pathological processes and play a role in the pathogenesis of …
Transglutaminase in neurological disease.
Hoffner G, Djian P. Hoffner G, et al. Oncotarget. 2017 Jul 31;8(34):55772-55773. doi: 10.18632/oncotarget.19694. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915550 Free PMC article. No abstract available.
New insight into transglutaminase 2 and link to neurodegenerative diseases.
Min B, Chung KC. Min B, et al. BMB Rep. 2018 Jan;51(1):5-13. doi: 10.5483/bmbrep.2018.51.1.227. BMB Rep. 2018. PMID: 29187283 Free PMC article. Review.
Formation of toxic protein aggregates is a common feature and mainly contributes to the pathogenesis of neurodegenerative diseases (NDDs), which include amyotrophic lateral sclerosis (ALS), Alzheimer's, Parkinson's, Huntington's, and prion diseases. The transglutami …
Formation of toxic protein aggregates is a common feature and mainly contributes to the pathogenesis of neurodegenerative diseases (NDDs), w …
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Martin A, Giuliano A, Collaro D, De Vivo G, Sedia C, Serretiello E, Gentile V. Martin A, et al. Amino Acids. 2013 Jan;44(1):111-8. doi: 10.1007/s00726-011-1081-1. Epub 2011 Sep 22. Amino Acids. 2013. PMID: 21938398 Review.
Transglutaminase activity has been hypothesized to be involved also in the pathogenetic mechanisms responsible for human neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, supranuclear palsy, Hunti …
Transglutaminase activity has been hypothesized to be involved also in the pathogenetic mechanisms responsible for human neurodegenerative d …
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Iannaccone M, Titta F, Serretiello E, De Vivo G, Martin A, Gentile V. Iannaccone M, et al. Recent Pat CNS Drug Discov. 2013 Dec;8(3):235-42. doi: 10.2174/1574889808666131128105630. Recent Pat CNS Drug Discov. 2013. PMID: 24286449 Review.
For example, neurodegenerative diseases, such as Alzheimer's Disease, Parkinson's Disease, supranuclear palsy, Huntington's Disease and other polyglutamine diseases, are characterized in part by aberrant cerebral transglutaminase activity and by …
For example, neurodegenerative diseases, such as Alzheimer's Disease, Parkinson's Disease, supranuclear palsy, H …
Transglutaminase and diseases of the central nervous system.
Hoffner G, Djian P. Hoffner G, et al. Front Biosci. 2005 Sep 1;10:3078-92. doi: 10.2741/1764. Front Biosci. 2005. PMID: 15970562 Review.
Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insoluble protein aggregates and neuronal death. ...
Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insoluble pr …
Transglutaminase 2 in neurodegenerative disorders.
Ruan Q, Johnson GV. Ruan Q, et al. Front Biosci. 2007 Jan 1;12:891-904. doi: 10.2741/2111. Front Biosci. 2007. PMID: 17127346 Review.
Most importantly, numerous studies have presented data demonstrating that dysregulation of TG2 may contribute to the pathogenesis of many neurodegenerative disorders, including Huntington's disease, Alzheimer's disease, Parkinson's disease
Most importantly, numerous studies have presented data demonstrating that dysregulation of TG2 may contribute to the pathogenesis of many ne …
Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
Wilhelmus MM, van Dam AM, Drukarch B. Wilhelmus MM, et al. Eur J Pharmacol. 2008 May 13;585(2-3):464-72. doi: 10.1016/j.ejphar.2008.01.059. Epub 2008 Mar 18. Eur J Pharmacol. 2008. PMID: 18417122 Review.
Alzheimer's disease, Parkinson's disease and Huntington's disease are neurodegenerative diseases, characterized by the accumulation and deposition of neurotoxic protein aggregates. ...So far, increased levels and activity of tissue transglutamin …
Alzheimer's disease, Parkinson's disease and Huntington's disease are neurodegenerative diseases, charact …
58 results